Zobrazeno 1 - 10 of 480 pro vyhledávání: '"R D, Lopes"'
1
Akademický článek
Endotoxemic shock from urinary calculus dog
Autor: V. F. P. Rispoli, R. D. Lopes, J. L. Dullius, V. L. A. Ruiz
Publikováno v: Scientific Electronic Archives, Vol 11, Iss 3, Pp 43-51 (2018)
This study aims to present a case of a dog of the Bichon Frizé breed, male that arrived on the 06/08/2015 at Provet - Moema Pathology Service for a necropsy. According to the history provided by the owner, four days before the death of the animal, t
Externí odkaz: https://doaj.org/article/e542942cbc22402d8f7d1554a6f0dd2d
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Causes of death in patients with chronic kidney disease: insights from the ASCEND-D and ASCEND-ND cardiovascular outcomes trials
Autor: A K Singh, A Acharya, K Carroll, R D Lopes, F R McCausland, L Mulloy, V Perkovic, S Solomon, S S Waikar, C Wanner, M G Wong, A R Cobitz, S A Mallett, B C Shaddinger, J J V McMurray
Publikováno v: European Heart Journal. 43
Background There are limited contemporary data available regarding adjudicated causes of death in patients with chronic kidney disease (CKD). Prior studies have indicated that cardiovascular (CV) events are one of the most common causes of death amon
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::24edb70151341052045d6ff69eeea67f
https://doi.org/10.1093/eurheartj/ehac544.1053
Zobrazit plný text záznamu
4
Causes of death in patients with atrial fibrillation and a recent acute coronary syndrome or percutaneous coronary intervention: insights from the AUGUSTUS trial
Autor: P Guimaraes, D M Wojdyla, J H Alexander, S G Goodman, R Aronson, S Windecker, R Mehran, C B Granger, R D Lopes
Publikováno v: European Heart Journal. 43
Background Patients with atrial fibrillation (AF) and concomitant coronary artery disease are at increased risk for poor outcomes. Less is known about specific causes of death in this population. Methods We describe specific causes of death among pat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fe526c633666e3c7918d2ecdec1a3749
https://doi.org/10.1093/eurheartj/ehac544.626
Zobrazit plný text záznamu
5
Variables associated with bleeding and thrombotic outcomes among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomised clinical trial
Autor: P G Barros E Silva, R D Lopes, R H M Furtado, A V S Macedo, B Bronhara, L P Damiani, L M Barbosa, J A Morata, E Ramacciotti, P A Martins, A L De Oliveira, V S Nunes, L E F Ritt, A T Rocha, L Tramujas
Publikováno v: European Heart Journal. 43
Background In the ACTION trial, therapeutic anticoagulation did not show benefit on mortality, days of hospitalization and oxygens therapy at 30 days among patients with COVID19. However, this strategy was associated with higher rate of bleeding and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::63a4f83e64408d4a2d036240a0118b11
https://doi.org/10.1093/eurheartj/ehac544.1492
Zobrazit plný text záznamu
6
Reduced dose, but not reduced risk: rates of inappropriate apixaban dose reduction and stroke and bleeding incidence
Autor: J Harrington, K Arps, A Wu, A P Carnicelli, K Chiswell, E Chrischilles, G Shantha, J Vanwormer, H Mundl, T Viethan, J H Alexander, R D Lopes, J Washam, M R Patel
Publikováno v: European Heart Journal. 43
Introduction Patients with atrial fibrillation (AF) should be prescribed standard-dose (5mg twice daily) apixaban for stroke prevention unless they meet 2 or more criteria: age ≥80, weight ≤60kg, and/or creatinine ≤1.5mg/dL, in which case a red
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::86a0e6e6b55057789c1bc10da1074ff3
https://doi.org/10.1093/eurheartj/ehac544.2709
Zobrazit plný text záznamu
7
The first Brazilian cardiovascular registry of atrial fibrillation: the primary results of the RECALL study
Autor: R D Lopes, P G Barros E Silva, C R Hoffmann Filho, M A Cavalvante, C M Miranda, R B Esper, G G De Lima, L E F Ritt, R M F L Silva, M Nakazone, L I Zimerman, O F De Souza, A A Fagundes, E B Saad, R A Teixeira
Publikováno v: European Heart Journal. 43
Background There is limited prospective real-world evidence of patients with atrial fibrillation (AF) in Latin America. Methods The rationale and design of the study were previously published (1). Briefly, RECALL was the first nationwide prospective
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8447c04d2000a365f201d235daf4ca43
https://doi.org/10.1093/eurheartj/ehac544.523
Zobrazit plný text záznamu
8
Main results of the first Brazilian Registry of Heart Failure (BREATHE)
Autor: D C Albuquerque, P G Barros E Silva, R D Lopes, C Hoffmann, P R Nogueira, H Reis, F A Nishijuka, J A De Figueiredo Neto, J D De Souza Neto, L E P Rohde, M V Simoes, R M Rocha, L Z Moura, F G Marcondes-Braga, E T Mesquita
Publikováno v: European Heart Journal. 43
Background Heart failure represents a common cause of hospitalization associated with poor short-term clinical outcomes. Little is known about the long-term prognosis of these patients in Latin America. Methods The rationale and design of the study w
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0ffdf8d26aa57e4e014c8263cb36d15a
https://doi.org/10.1093/eurheartj/ehac544.1078
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje